A cost-consequence analysis of hepatitis B screening in an immigrant population

Ann Ist Super Sanita. 2015;51(4):327-35. doi: 10.4415/ANN_15_04_13.

Abstract

Objective: Screening for HBV among groups at risk, such as migrant populations, has proved to be a cost-effective strategy. With a view to advising local policy-makers, the cost-consequences of HBV screening was assessed using a modeling approach.

Methods: This cost-consequence analysis of an HBV screening strategy was conducted in a cohort of adult migrants in the province of Padua, northern Italy.

Results: The population targeted for screening consisted of 65 405 migrants, among whom the weighted rate for the prevalence of HBV was 0.04972, with 3251 people infected. Over a period of 5 years, the screening strategy prevented 565 cases/year of chronic hepatitis, 141 of compensated cirrhosis, 9 of decompensated cirrhosis, 14 hepatocellular carcinomas and 12 deaths. The above data revealed that the incremental cost of the screening strategy compared to no screening strategy was € 7 974 959 over the five year period. The cost per life saved amounted to € 676 709.

Conclusions: The present study provides useful information to policy-makers at local and regional levels.

MeSH terms

  • Adult
  • Carcinoma, Hepatocellular / diagnosis
  • Carcinoma, Hepatocellular / epidemiology
  • Cohort Studies
  • Cost-Benefit Analysis
  • Emigrants and Immigrants*
  • Hepatitis B / diagnosis*
  • Hepatitis B / economics*
  • Hepatitis B / epidemiology
  • Humans
  • Italy / epidemiology
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / epidemiology
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / epidemiology
  • Mass Screening / economics
  • Prevalence
  • Vaccination